Clinical trial
The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With…
NCT00103948 · Eisai Limited, Industry · Completed
Key facts
| NCT number | NCT00103948 |
|---|---|
| Title | The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment |
| Official title | An 18-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment |
| Lead sponsor | Eisai Limited, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cognitive Impairment |
| Intervention type | Drug |
| Interventions | Aricept |
| Enrollment | 165 |
| Start date | Feb 1, 2005 |
| Primary completion | Oct 1, 2006 |
| Completion | Feb 1, 2007 |
| First posted | Feb 18, 2005 |
| Last update posted | Nov 3, 2015 |
| Countries | Australia, Spain, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: